(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Ecopetrol S.A., GlaxoSmithKline, and Flex.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Ecopetrol S.A. (EC) 15.10 6.79% 2022-01-18 06:51:02
2 GlaxoSmithKline (GSK) 46.84 3.01% 2022-01-18 04:42:00
3 Flex (FLEX) 18.81 2.96% 2022-01-18 07:11:18
4 ImmunoGen (IMGN) 6.68 2.93% 2022-01-18 07:12:09
5 Vodafone (VOD) 16.86 2.49% 2022-01-18 06:59:55
6 Fresenius Medical Care AG (FMS) 34.62 2.43% 2022-01-18 07:21:33
7 Brookfield Infrastructure Partners (BIP) 61.00 2.4% 2022-01-18 04:39:04
8 Cenovus Energy (CVE) 15.20 2.36% 2022-01-18 04:55:24
9 Apache (APA) 33.98 2.07% 2022-01-18 07:15:34
10 Transocean (RIG) 3.59 1.99% 2022-01-18 05:00:42

The three most active and biggest losers today are Unilever, Kodak, and Catalent.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Unilever (UL) 48.80 -10.11% 2022-01-18 05:02:41
2 Kodak (KODK) 4.12 -8.65% 2022-01-18 04:58:17
3 Catalent (CTLT) 102.01 -5.76% 2022-01-18 07:20:40
4 Towers Watson & Co (TW) 87.00 -5.14% 2022-01-18 07:18:10
5 SmileDirectClub (SDC) 2.15 -4.44% 2022-01-18 07:33:20
6 Gap (GPS) 17.47 -4.38% 2022-01-18 04:57:04
7 Wipro Limited (WIT) 8.21 -4.31% 2022-01-18 05:03:16
8 Yandex (YNDX) 50.14 -4.2% 2022-01-18 07:30:44
9 BioNTech SE (BNTX) 187.77 -4.2% 2022-01-18 04:52:02
10 Logitech (LOGI) 81.51 -4.03% 2022-01-18 07:27:51

Most Active Premarket Winners today

1. Ecopetrol S.A. (EC) – Premarket: 6.79%

NYSE ended the session with Ecopetrol S.A. jumping 0.57% to $14.14 on Tuesday, after five successive sessions in a row of gains. NYSE slid 0.23% to $17,219.06, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for Ecopetrol S.A. is 796500, 16.23% above its average volume of 685255.

Ecopetrol S.A.’s last close was $14.14, 11.13% below its 52-week high of $15.91.

Ecopetrol S.A.’s Sales

Ecopetrol S.A.’s sales growth is 75.8% for the current quarter and 53% for the next. The company’s growth estimates for the current quarter and the next is 454.5% and 600%, respectively.

Volatility

Ecopetrol S.A.’s last week, last month’s, and last quarter’s current intraday variation average was 0.93%, 0.30%, and 1.77%, respectively.

Ecopetrol S.A.’s highest amplitude of average volatility was 0.93% (last week), 1.80% (last month), and 1.77% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Ecopetrol S.A.’s stock is considered to be oversold (<=20).

Ecopetrol S.A.’s Stock Yearly Top and Bottom Value

Ecopetrol S.A.’s stock is valued at $14.14 at 07:34 EST, way under its 52-week high of $15.91 and way above its 52-week low of $11.37.

Ecopetrol S.A.’s Moving Average

Ecopetrol S.A.’s value is below its 50-day moving average of $14.56 and above its 200-day moving average of $13.53.

More news about Ecopetrol S.A..

2. GlaxoSmithKline (GSK) – Premarket: 3.01%

NYSE ended the session with GlaxoSmithKline jumping 0.91% to $45.47 on Tuesday, following the last session’s upward trend. NYSE fell 0.23% to $17,219.06, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for GlaxoSmithKline is 4040680, 0.54% above its average volume of 4018780.

GlaxoSmithKline’s last close was $45.47, 4.27% above its 52-week high of $43.61.

GlaxoSmithKline’s Sales

GlaxoSmithKline’s sales growth is 7.9% for the present quarter and 6.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 14% and a negative 1.6%, respectively.

GlaxoSmithKline’s Revenue

Year-on-year quarterly revenue growth declined by 18.4%, now sitting on 32.43B for the twelve trailing months.

Volatility

GlaxoSmithKline’s last week, last month’s, and last quarter’s current intraday variation average was 0.14%, 0.20%, and 0.77%, respectively.

GlaxoSmithKline’s highest amplitude of average volatility was 0.54% (last week), 0.64% (last month), and 0.77% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

GlaxoSmithKline’s stock is considered to be oversold (<=20).

GlaxoSmithKline’s Stock Yearly Top and Bottom Value

GlaxoSmithKline’s stock is valued at $45.47 at 07:34 EST, above its 52-week high of $43.61.

GlaxoSmithKline’s Moving Average

GlaxoSmithKline’s worth is way higher than its 50-day moving average of $39.98 and way higher than its 200-day moving average of $39.80.

Previous days news about GlaxoSmithKline

  • Glaxosmithkline up 4% after failed $68b unilever bid for consumer health unit. According to MarketWatch on Monday, 17 January, "LONDON – The pharmaceutical giant GlaxoSmithKline said Saturday it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit, a joint venture it controls in a partnership with Pfizer."
  • Glaxosmithkline shares soar after unilever bid for consumer health unit. According to MarketWatch on Monday, 17 January, "Shares of GlaxoSmithKline surged on Monday, while Unilever stock tumbled following a failed $68 billion bid by the latter to acquire the pharmaceutical giant’s consumer healthcare arm.", "Driving the FTSE 100 higher and at the top of the Stoxx Europe 600’s gainer’s list, was GlaxoSmithKline , up 5% after saying Saturday that it has rejected an unsolicited £50 billion ($68.4 billion) Unilever offer for the unit behind painkiller Advil and Sensodyne toothpaste that it jointly owns with Pfizer . "

More news about GlaxoSmithKline.

3. Flex (FLEX) – Premarket: 2.96%

NASDAQ ended the session with Flex jumping 1.27% to $18.27 on Tuesday while NASDAQ rose 0.59% to $14,893.75.

Volume

Today’s last reported volume for Flex is 3180660, 16.99% below its average volume of 3832010.

Flex’s last close was $18.27, 8.83% under its 52-week high of $20.04.

The company’s growth estimates for the ongoing quarter is 11.1% and a drop 2% for the next.

Flex’s Revenue

Year-on-year quarterly revenue growth grew by 23.1%, now sitting on 25.31B for the twelve trailing months.

Volatility

Flex’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.06%, a positive 0.30%, and a positive 1.88%, respectively.

Flex’s highest amplitude of average volatility was 0.90% (last week), 1.43% (last month), and 1.88% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Flex’s stock is considered to be oversold (<=20).

Flex’s Stock Yearly Top and Bottom Value

Flex’s stock is valued at $18.27 at 07:34 EST, below its 52-week high of $20.04 and way higher than its 52-week low of $15.51.

Flex’s Moving Average

Flex’s worth is higher than its 50-day moving average of $18.08 and higher than its 200-day moving average of $17.93.

More news about Flex.

4. ImmunoGen (IMGN) – Premarket: 2.93%

NASDAQ ended the session with ImmunoGen rising 0.46% to $6.49 on Tuesday while NASDAQ rose 0.59% to $14,893.75.

Volume

Today’s last reported volume for ImmunoGen is 1824040, 54.83% below its average volume of 4038580.

ImmunoGen’s last close was $6.49, 40.35% under its 52-week high of $10.88.

ImmunoGen’s Sales

ImmunoGen’s sales growth is 23.9% for the present quarter and a decline by 78% for the next. The company’s growth estimates for the present quarter and the next is a negative 38.5% and a negative 237.5%, respectively.

ImmunoGen’s Revenue

Year-on-year quarterly revenue growth grew by 18.2%, now sitting on 134.72M for the twelve trailing months.

Volatility

ImmunoGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.46%, a negative 0.45%, and a positive 3.17%, respectively.

ImmunoGen’s highest amplitude of average volatility was 3.77% (last week), 2.39% (last month), and 3.17% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ImmunoGen’s stock is considered to be overbought (>=80).

ImmunoGen’s Stock Yearly Top and Bottom Value

ImmunoGen’s stock is valued at $6.49 at 07:34 EST, way below its 52-week high of $10.88 and way higher than its 52-week low of $4.72.

ImmunoGen’s Moving Average

ImmunoGen’s worth is above its 50-day moving average of $5.98 and below its 200-day moving average of $6.53.

More news about ImmunoGen.

5. Vodafone (VOD) – Premarket: 2.49%

NASDAQ ended the session with Vodafone rising 1.23% to $16.45 on Tuesday while NASDAQ rose 0.59% to $14,893.75.

Volume

Today’s last reported volume for Vodafone is 8470960, 47.59% above its average volume of 5739140.

Vodafone’s last close was $16.45, 19.2% under its 52-week high of $20.36.

Vodafone’s Revenue

Year-on-year quarterly revenue growth declined by 2.8%, now sitting on 43.81B for the twelve trailing months.

Volatility

Vodafone’s last week, last month’s, and last quarter’s current intraday variation average was 0.76%, 0.41%, and 1.30%, respectively.

Vodafone’s highest amplitude of average volatility was 0.76% (last week), 1.37% (last month), and 1.30% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Vodafone’s stock is considered to be oversold (<=20).

Vodafone’s Stock Yearly Top and Bottom Value

Vodafone’s stock is valued at $16.45 at 07:34 EST, way under its 52-week high of $20.36 and way above its 52-week low of $14.53.

Vodafone’s Moving Average

Vodafone’s worth is above its 50-day moving average of $15.30 and under its 200-day moving average of $17.13.

More news about Vodafone.

6. Fresenius Medical Care AG (FMS) – Premarket: 2.43%

NYSE ended the session with Fresenius Medical Care AG rising 2.42% to $33.80 on Tuesday, after five successive sessions in a row of gains. NYSE slid 0.23% to $17,219.06, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 672277, 74.62% above its average volume of 384982.

Fresenius Medical Care AG’s last close was $33.80, 21.99% below its 52-week high of $43.33.

Fresenius Medical Care AG’s Sales

Fresenius Medical Care AG’s sales growth is a negative 5% for the present quarter and 27.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 26% and a negative 24.7%, respectively.

Fresenius Medical Care AG’s Revenue

Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.

Volatility

Fresenius Medical Care AG’s last week, last month’s, and last quarter’s current intraday variation average was 0.69%, 0.48%, and 1.10%, respectively.

Fresenius Medical Care AG’s highest amplitude of average volatility was 0.89% (last week), 1.06% (last month), and 1.10% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Fresenius Medical Care AG’s stock is considered to be oversold (<=20).

Fresenius Medical Care AG’s Stock Yearly Top and Bottom Value

Fresenius Medical Care AG’s stock is valued at $33.80 at 07:34 EST, way below its 52-week high of $43.33 and way higher than its 52-week low of $29.71.

Fresenius Medical Care AG’s Moving Average

Fresenius Medical Care AG’s value is higher than its 50-day moving average of $33.36 and way under its 200-day moving average of $37.59.

More news about Fresenius Medical Care AG.

7. Brookfield Infrastructure Partners (BIP) – Premarket: 2.4%

NYSE ended the session with Brookfield Infrastructure Partners jumping 0.44% to $59.57 on Tuesday while NYSE dropped 0.23% to $17,219.06.

Volume

Today’s last reported volume for Brookfield Infrastructure Partners is 247824, 25.74% below its average volume of 333757.

Brookfield Infrastructure Partners’s last close was $59.57, 3.45% under its 52-week high of $61.70.

The company’s growth estimates for the current quarter is 275% and a drop 56.9% for the next.

Brookfield Infrastructure Partners’s Revenue

Year-on-year quarterly revenue growth grew by 36.8%, now sitting on 10.09B for the twelve trailing months.

Volatility

Brookfield Infrastructure Partners’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.28%, a positive 0.23%, and a positive 0.77%, respectively.

Brookfield Infrastructure Partners’s highest amplitude of average volatility was 0.50% (last week), 0.77% (last month), and 0.77% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Brookfield Infrastructure Partners’s stock is considered to be oversold (<=20).

Brookfield Infrastructure Partners’s Stock Yearly Top and Bottom Value

Brookfield Infrastructure Partners’s stock is valued at $59.57 at 07:34 EST, below its 52-week high of $61.70 and way higher than its 52-week low of $48.25.

Brookfield Infrastructure Partners’s Moving Average

Brookfield Infrastructure Partners’s value is above its 50-day moving average of $57.64 and above its 200-day moving average of $55.66.

More news about Brookfield Infrastructure Partners.

8. Cenovus Energy (CVE) – Premarket: 2.36%

NYSE ended the session with Cenovus Energy jumping 3.2% to $14.85 on Tuesday, following the last session’s upward trend. NYSE slid 0.23% to $17,219.06, after two consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Cenovus Energy is 7395170, 22.11% below its average volume of 9495120.

Cenovus Energy’s last close was $14.85, 10.16% higher than its 52-week high of $13.48.

Cenovus Energy’s Sales

Cenovus Energy’s sales growth is 17.5% for the ongoing quarter and 11.2% for the next. The company’s growth estimates for the current quarter is 50% and a drop 78.6% for the next.

Cenovus Energy’s Revenue

Year-on-year quarterly revenue growth grew by 386.5%, now sitting on 26.82B for the twelve trailing months.

Volatility

Cenovus Energy’s last week, last month’s, and last quarter’s current intraday variation average was 1.63%, 1.45%, and 2.25%, respectively.

Cenovus Energy’s highest amplitude of average volatility was 1.94% (last week), 2.04% (last month), and 2.25% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Cenovus Energy’s stock is considered to be oversold (<=20).

Cenovus Energy’s Stock Yearly Top and Bottom Value

Cenovus Energy’s stock is valued at $14.85 at 07:34 EST, way above its 52-week high of $13.48.

Cenovus Energy’s Moving Average

Cenovus Energy’s value is way higher than its 50-day moving average of $11.31 and way above its 200-day moving average of $9.26.

More news about Cenovus Energy.

9. Apache (APA) – Premarket: 2.07%

NASDAQ ended the session with Apache jumping 3.74% to $33.29 on Tuesday, following the last session’s upward trend. NASDAQ jumped 0.59% to $14,893.75, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Apache is 10991300, 15.34% above its average volume of 9528970.

Apache’s last close was $33.29, 6.9% higher than its 52-week high of $31.14.

The company’s growth estimates for the current quarter and the next is 587.5% and 1860%, respectively.

Apache’s Revenue

Year-on-year quarterly revenue growth grew by 137.4%, now sitting on 6.03B for the twelve trailing months.

Volatility

Apache’s last week, last month’s, and last quarter’s current intraday variation average was 1.34%, 1.55%, and 2.77%, respectively.

Apache’s highest amplitude of average volatility was 2.51% (last week), 2.93% (last month), and 2.77% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Apache’s stock is considered to be oversold (<=20).

Apache’s Stock Yearly Top and Bottom Value

Apache’s stock is valued at $33.29 at 07:34 EST, higher than its 52-week high of $31.14.

Apache’s Moving Average

Apache’s worth is way higher than its 50-day moving average of $26.71 and way above its 200-day moving average of $21.57.

More news about Apache.

10. Transocean (RIG) – Premarket: 1.99%

NYSE ended the session with Transocean rising 3.53% to $3.52 on Tuesday, after two sequential sessions in a row of gains. NYSE dropped 0.23% to $17,219.06, after two successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Transocean is 11532200, 26.39% below its average volume of 15666700.

Transocean’s last close was $3.52, 31.38% under its 52-week high of $5.13.

Transocean’s Sales

Transocean’s sales growth is a negative 14.9% for the ongoing quarter and a decline by 7.3% for the next. The company’s growth estimates for the present quarter is a negative 36.4% and positive 52.9% for the next.

Transocean’s Revenue

Year-on-year quarterly revenue growth declined by 29.5%, now sitting on 2.77B for the twelve trailing months.

Volatility

Transocean’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.04%, a positive 0.56%, and a positive 3.41%, respectively.

Transocean’s highest amplitude of average volatility was 2.45% (last week), 3.26% (last month), and 3.41% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Transocean’s stock is considered to be oversold (<=20).

Transocean’s Stock Yearly Top and Bottom Value

Transocean’s stock is valued at $3.52 at 07:34 EST, way under its 52-week high of $5.13 and way higher than its 52-week low of $0.97.

Transocean’s Moving Average

Transocean’s value is below its 50-day moving average of $3.79 and under its 200-day moving average of $3.78.

More news about Transocean.

Most Active Premarket Losers Today

1. Unilever (UL) – Premarket: -10.11%

NYSE ended the session with Unilever jumping 1.14% to $54.29 on Tuesday, after five sequential sessions in a row of gains. NYSE fell 0.23% to $17,219.06, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Unilever is 2690120, 2.13% above its average volume of 2633820.

Unilever’s last close was $54.29, 13.89% below its 52-week high of $63.05.

Unilever’s Revenue

Year-on-year quarterly revenue growth grew by 0.3%, now sitting on 50.8B for the twelve trailing months.

Volatility

Unilever’s last week, last month’s, and last quarter’s current intraday variation average was 0.03%, 0.15%, and 0.69%, respectively.

Unilever’s highest amplitude of average volatility was 0.55% (last week), 0.51% (last month), and 0.69% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Unilever’s stock is considered to be oversold (<=20).

Unilever’s Stock Yearly Top and Bottom Value

Unilever’s stock is valued at $54.29 at 07:34 EST, way below its 52-week high of $63.05 and higher than its 52-week low of $51.98.

Unilever’s Moving Average

Unilever’s worth is higher than its 50-day moving average of $53.48 and under its 200-day moving average of $57.01.

Previous days news about Unilever

  • Unilever needs $10 billion bump to win glaxo unit, analysts say. According to Bloomberg Quint on Monday, 17 January, "While Unilever could increase its offer to about 55 billion pounds, "we are very doubtful this will be sufficient to persuade the GSK board or GSK investors," analysts at Citigroup Inc. wrote in a report Monday. ", "Analysts who follow Unilever scorned the proposed acquisition, saying it doesn’t make sense and would be too expensive."
  • Glaxosmithkline shares soar after unilever bid for consumer health unit. According to MarketWatch on Monday, 17 January, "Shares of GlaxoSmithKline surged on Monday, while Unilever stock tumbled following a failed $68 billion bid by the latter to acquire the pharmaceutical giant’s consumer healthcare arm.", "Driving the FTSE 100 higher and at the top of the Stoxx Europe 600’s gainer’s list, was GlaxoSmithKline , up 5% after saying Saturday that it has rejected an unsolicited £50 billion ($68.4 billion) Unilever offer for the unit behind painkiller Advil and Sensodyne toothpaste that it jointly owns with Pfizer . "
  • Unilever confirms takeover bid for gsk’s consumer goods business. According to Bloomberg Quint on Saturday, 15 January, "The statement follows a Times report saying that Glaxo rejected an unsolicited takeover offer from Unilever for its consumer goods unit that valued the business at about 50 billion pounds (($68.4 billion)."
  • Unilever (ulvr stock) share price slides as glaxo consumer bid confirmed. According to FXStreet on Monday, 17 January, "On the corporate front the main story at the weekend was the £50bn bid by Unilever for GlaxoSmithKline’s consumer healthcare business, of which it owns a 68% stake along with Pfizer, which Glaxo said it had rejected, no doubt in the hope that Unilever will come back with a higher offer, with the sum of £60bn being bandied about according to some estimates.", "It might be for GlaxoSmithkline and Pfizer, however there is a feeling that for Unilever it could well prove to be too high a price."
  • Glaxosmithkline up 4% after failed $68b unilever bid for consumer health unit. According to MarketWatch on Monday, 17 January, "Consumer goods conglomerate Unilever sells a wide assortment of consumer products from Hellmann’s mayonnaise to Lipton tea and Ben & Jerry’s ice cream. ", "LONDON – The pharmaceutical giant GlaxoSmithKline said Saturday it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit, a joint venture it controls in a partnership with Pfizer."

More news about Unilever.

2. Kodak (KODK) – Premarket: -8.65%

NYSE ended the session with Kodak rising 0.22% to $4.51 on Tuesday while NYSE slid 0.23% to $17,219.06.

Volume

Today’s last reported volume for Kodak is 1463060, 25.78% below its average volume of 1971300.

Kodak’s last close was $4.51, 68.19% below its 52-week high of $14.18.

Kodak’s Revenue

Year-on-year quarterly revenue growth declined by 0.7%, now sitting on 1.03B for the twelve trailing months.

Volatility

Kodak’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.56%, a positive 0.23%, and a positive 3.03%, respectively.

Kodak’s highest amplitude of average volatility was 0.67% (last week), 2.39% (last month), and 3.03% (last quarter), respectively.

Kodak’s Stock Yearly Top and Bottom Value

Kodak’s stock is valued at $4.51 at 07:34 EST, way below its 52-week low of $6.29.

Kodak’s Moving Average

Kodak’s worth is way below its 50-day moving average of $6.96 and way under its 200-day moving average of $7.44.

More news about Kodak.

3. Catalent (CTLT) – Premarket: -5.76%

NYSE ended the session with Catalent falling 1.58% to $108.24 on Tuesday while NYSE fell 0.23% to $17,219.06.

Volume

Today’s last reported volume for Catalent is 1291690, 21.46% above its average volume of 1063420.

Catalent’s last close was $108.24, 24.12% below its 52-week high of $142.64.

The company’s growth estimates for the ongoing quarter and the next is 51.2% and 25.4%, respectively.

Catalent’s Revenue

Year-on-year quarterly revenue growth grew by 25.4%, now sitting on 4B for the twelve trailing months.

Volatility

Catalent’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.04%, a negative 1.02%, and a positive 2.03%, respectively.

Catalent’s highest amplitude of average volatility was 3.04% (last week), 2.05% (last month), and 2.03% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalent’s stock is considered to be overbought (>=80).

Catalent’s Stock Yearly Top and Bottom Value

Catalent’s stock is valued at $108.24 at 07:34 EST, way under its 52-week high of $142.64 and way higher than its 52-week low of $95.79.

Catalent’s Moving Average

Catalent’s worth is way under its 50-day moving average of $129.34 and below its 200-day moving average of $118.20.

More news about Catalent.

4. Towers Watson & Co (TW) – Premarket: -5.14%

NASDAQ ended the session with Towers Watson & Co rising 0.07% to $91.71 on Tuesday while NASDAQ rose 0.59% to $14,893.75.

Volume

Today’s last reported volume for Towers Watson & Co is 550848, 11.76% below its average volume of 624306.

Towers Watson & Co’s last close was $91.71, 7.6% under its 52-week high of $99.25.

Towers Watson & Co’s Sales

Towers Watson & Co’s sales growth is 22.2% for the ongoing quarter and 16.5% for the next. The company’s growth estimates for the present quarter and the next is 26.7% and 20.6%, respectively.

Towers Watson & Co’s Revenue

Year-on-year quarterly revenue growth grew by 24.7%, now sitting on 1.03B for the twelve trailing months.

Volatility

Towers Watson & Co’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.82%, a negative 0.29%, and a positive 1.16%, respectively.

Towers Watson & Co’s highest amplitude of average volatility was 0.93% (last week), 1.48% (last month), and 1.16% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Towers Watson & Co’s stock is considered to be overbought (>=80).

Towers Watson & Co’s Stock Yearly Top and Bottom Value

Towers Watson & Co’s stock is valued at $91.71 at 07:34 EST, under its 52-week high of $99.25 and way above its 52-week low of $59.35.

Towers Watson & Co’s Moving Average

Towers Watson & Co’s value is above its 50-day moving average of $90.82 and above its 200-day moving average of $84.46.

More news about Towers Watson & Co.

5. SmileDirectClub (SDC) – Premarket: -4.44%

NASDAQ ended the session with SmileDirectClub jumping 14.21% to $2.25 on Tuesday while NASDAQ rose 0.59% to $14,893.75.

Volume

Today’s last reported volume for SmileDirectClub is 33750800, 239.19% above its average volume of 9950410.

SmileDirectClub’s last close was $2.25, 86.01% under its 52-week high of $16.08.

SmileDirectClub’s Sales

SmileDirectClub’s sales growth is 25.6% for the current quarter and 10% for the next. The company’s growth estimates for the current quarter and the next is a negative 18.2% and a negative 33.3%, respectively.

SmileDirectClub’s Revenue

Year-on-year quarterly revenue growth grew by 62.7%, now sitting on 726.7M for the twelve trailing months.

Volatility

SmileDirectClub’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.24%, a negative 0.40%, and a positive 5.52%, respectively.

SmileDirectClub’s highest amplitude of average volatility was 7.23% (last week), 6.29% (last month), and 5.52% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

SmileDirectClub’s stock is considered to be oversold (<=20).

SmileDirectClub’s Stock Yearly Top and Bottom Value

SmileDirectClub’s stock is valued at $2.25 at 07:34 EST, way under its 52-week low of $2.54.

SmileDirectClub’s Moving Average

SmileDirectClub’s value is way below its 50-day moving average of $4.62 and way below its 200-day moving average of $7.31.

More news about SmileDirectClub.

6. Gap (GPS) – Premarket: -4.38%

NYSE ended the session with Gap falling 0.87% to $18.27 on Tuesday, following the last session’s downward trend. NYSE dropped 0.23% to $17,219.06, after two sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Gap is 10086500, 12.42% above its average volume of 8971660.

Gap’s last close was $18.27, 51.45% below its 52-week high of $37.63.

The company’s growth estimates for the present quarter and the next is 108% and 82.1%, respectively.

Gap’s Revenue

Year-on-year quarterly revenue growth grew by 28.6%, now sitting on 16.62B for the twelve trailing months.

Volatility

Gap’s last week, last month’s, and last quarter’s current intraday variation average was 1.51%, 0.87%, and 2.40%, respectively.

Gap’s highest amplitude of average volatility was 2.32% (last week), 1.93% (last month), and 2.40% (last quarter), respectively.

Gap’s Stock Yearly Top and Bottom Value

Gap’s stock is valued at $18.27 at 07:34 EST, below its 52-week low of $19.10.

Gap’s Moving Average

Gap’s worth is way under its 50-day moving average of $23.46 and way under its 200-day moving average of $28.65.

More news about Gap.

7. Wipro Limited (WIT) – Premarket: -4.31%

NYSE ended the session with Wipro Limited dropping 0.58% to $8.58 on Tuesday, after five successive sessions in a row of losses. NYSE slid 0.23% to $17,219.06, after two sequential sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Wipro Limited is 2009670, 13.39% above its average volume of 1772350.

Wipro Limited’s last close was $8.58, 13.86% under its 52-week high of $9.96.

Wipro Limited’s Revenue

Year-on-year quarterly revenue growth grew by 3.4%, now sitting on 619.43B for the twelve trailing months.

Volatility

Wipro Limited’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.16%, a negative 0.45%, and a positive 1.36%, respectively.

Wipro Limited’s highest amplitude of average volatility was 4.16% (last week), 1.80% (last month), and 1.36% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Wipro Limited’s stock is considered to be overbought (>=80).

Wipro Limited’s Stock Yearly Top and Bottom Value

Wipro Limited’s stock is valued at $8.58 at 07:34 EST, way below its 52-week high of $9.96 and way above its 52-week low of $4.96.

Wipro Limited’s Moving Average

Wipro Limited’s value is below its 50-day moving average of $9.20 and above its 200-day moving average of $8.50.

More news about Wipro Limited.

8. Yandex (YNDX) – Premarket: -4.2%

NASDAQ ended the session with Yandex dropping 3.98% to $52.34 on Tuesday, after two sequential sessions in a row of losses. NASDAQ rose 0.59% to $14,893.75, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Yandex is 2814160, 58.5% above its average volume of 1775450.

Yandex’s last close was $52.34, 39.92% under its 52-week high of $87.11.

Yandex’s Sales

Yandex’s sales growth is 46.1% for the current quarter and 48.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 82.8% and a negative 4.3%, respectively.

Yandex’s Revenue

Year-on-year quarterly revenue growth grew by 96.6%, now sitting on 284.47B for the twelve trailing months.

Volatility

Yandex’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.63%, a negative 0.93%, and a positive 1.89%, respectively.

Yandex’s highest amplitude of average volatility was 4.60% (last week), 2.48% (last month), and 1.89% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Yandex’s stock is considered to be overbought (>=80).

Yandex’s Stock Yearly Top and Bottom Value

Yandex’s stock is valued at $52.34 at 07:34 EST, way under its 52-week low of $58.91.

Yandex’s Moving Average

Yandex’s value is way under its 50-day moving average of $77.08 and way below its 200-day moving average of $70.92.

More news about Yandex.

9. BioNTech SE (BNTX) – Premarket: -4.2%

NASDAQ ended the session with BioNTech SE sliding 3.44% to $196.00 on Tuesday while NASDAQ jumped 0.59% to $14,893.75.

Volume

Today’s last reported volume for BioNTech SE is 3737690, 12.53% above its average volume of 3321420.

BioNTech SE’s last close was $196.00, 57.76% under its 52-week high of $464.00.

The company’s growth estimates for the current quarter and the next is 1188.8% and 438%, respectively.

BioNTech SE’s Revenue

Year-on-year quarterly revenue growth grew by 12630.2%, now sitting on 7.77B for the twelve trailing months.

Volatility

BioNTech SE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.30%, a negative 2.88%, and a positive 5.51%, respectively.

BioNTech SE’s highest amplitude of average volatility was 5.18% (last week), 4.71% (last month), and 5.51% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

BioNTech SE’s stock is considered to be overbought (>=80).

BioNTech SE’s Stock Yearly Top and Bottom Value

BioNTech SE’s stock is valued at $196.00 at 07:34 EST, way below its 52-week high of $464.00 and way higher than its 52-week low of $80.55.

BioNTech SE’s Moving Average

BioNTech SE’s value is way under its 50-day moving average of $269.93 and way below its 200-day moving average of $268.56.

More news about BioNTech SE.

10. Logitech (LOGI) – Premarket: -4.03%

NASDAQ ended the session with Logitech rising 2.93% to $84.93 on Tuesday while NASDAQ jumped 0.59% to $14,893.75.

Volume

Today’s last reported volume for Logitech is 1002770, 18.64% above its average volume of 845214.

Logitech’s last close was $84.93, 39.41% under its 52-week high of $140.17.

The company’s growth estimates for the ongoing quarter and the next is a negative 41.2% and a negative 45.3%, respectively.

Logitech’s Revenue

Year-on-year quarterly revenue growth grew by 65.7%, now sitting on 5.77B for the twelve trailing months.

Volatility

Logitech’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.40%, a positive 0.35%, and a positive 1.45%, respectively.

Logitech’s highest amplitude of average volatility was 2.35% (last week), 1.77% (last month), and 1.45% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Logitech’s stock is considered to be oversold (<=20).

Logitech’s Stock Yearly Top and Bottom Value

Logitech’s stock is valued at $84.93 at 07:34 EST, way below its 52-week high of $140.17 and way above its 52-week low of $76.70.

Logitech’s Moving Average

Logitech’s value is above its 50-day moving average of $83.32 and way under its 200-day moving average of $104.07.

More news about Logitech.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here